165 related articles for article (PubMed ID: 31058601)
1. The Clinical Benefit of Device Therapy for Meniere's Disease in Adults: Systematic Review and Meta-Analysis.
Wang SJ; Yang H; Yao YY; Gu HY; Lin LL; Zhang C; Luo J
J Int Adv Otol; 2019 Apr; 15(1):121-129. PubMed ID: 31058601
[TBL] [Abstract][Full Text] [Related]
2. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Standring R; Wang Y
Laryngoscope; 2015 Jan; 125(1):203-8. PubMed ID: 24913022
[TBL] [Abstract][Full Text] [Related]
4. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
[TBL] [Abstract][Full Text] [Related]
5. Meniett Therapy for Ménière's Disease: An Updated Meta-analysis.
Zhang SL; Leng Y; Liu B; Shi H; Lu M; Kong WJ
Otol Neurotol; 2016 Mar; 37(3):290-8. PubMed ID: 26808558
[TBL] [Abstract][Full Text] [Related]
6. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
8. Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: a systematic review of randomised controlled trials.
Syed MI; Rutka JA; Hendry J; Browning GG
Clin Otolaryngol; 2015 Jun; 40(3):197-207. PubMed ID: 25346252
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
10. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
Gates GA; Green JD
Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
[TBL] [Abstract][Full Text] [Related]
11. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
12. Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.
Buchanan MA; Rai A; Prinsley PR
J Laryngol Otol; 2010 Oct; 124(10):1067-72. PubMed ID: 20537216
[TBL] [Abstract][Full Text] [Related]
13. Positive pressure therapy for Ménières disease.
Holmberg J; de Amesti M; Rosenbaum A; Winter M
Medwave; 2019 Apr; 19(3):e7610. PubMed ID: 30985738
[TBL] [Abstract][Full Text] [Related]
14. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière's disease: a clinical placebo-controlled study.
Densert B; Densert O; Arlinger S; Sass K; Odkvist L
Am J Otol; 1997 Nov; 18(6):726-33. PubMed ID: 9391668
[TBL] [Abstract][Full Text] [Related]
15. Reduction in sick leave and costs to society of patients with Meniere's disease after treatment of temporomandibular and cervical spine disorders: a controlled six-year cost-benefit study.
Bjorne A; Agerberg G
Cranio; 2003 Apr; 21(2):136-43. PubMed ID: 12723860
[TBL] [Abstract][Full Text] [Related]
16. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
17. Meniett device in meniere disease: Randomized, double-blind, placebo-controlled multicenter trial.
Russo FY; Nguyen Y; De Seta D; Bouccara D; Sterkers O; Ferrary E; Bernardeschi D
Laryngoscope; 2017 Feb; 127(2):470-475. PubMed ID: 27515294
[TBL] [Abstract][Full Text] [Related]
18. Delayed Effect of Active Pressure Treatment on Endolymphatic Hydrops.
Covelli E; Volpini L; Atturo F; Benincasa AT; Filippi C; Tarentini S; Marrone V; Monini S; Vestri A; Barbara M
Audiol Neurootol; 2017; 22(1):24-29. PubMed ID: 28514787
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic steroids for Ménière's disease or syndrome.
Phillips JS; Westerberg B
Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
[TBL] [Abstract][Full Text] [Related]
20. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
Barbara M; Consagra C; Monini S; Nostro G; Harguindey A; Vestri A; Filipo R
Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]